Bijal Shah
MD, MS
Senior Member, Department of Malignant Hematology
👥Biography 个人简介
Bijal Shah is a leading investigator in immunotherapy approaches for adult ALL, with expertise in blinatumomab, inotuzumab ozogamicin, and CAR-T cell therapy. He has led clinical trials evaluating novel sequencing of immunotherapy in frontline and relapsed/refractory ALL. His work on MRD-guided immunotherapy escalation has helped define modern all-oral maintenance regimens in adult ALL.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Bijal Shah 的研究动态
Follow Bijal Shah's research updates
留下邮箱，当我们发布与 Bijal Shah（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment